Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management

NCT04521790 is registered in ClinicalTrials.gov with Scientific Institute San Raffaele as lead sponsor.

NCT NCT04521790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04521790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management
Lead sponsor
Scientific Institute San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
January 30, 2018
Completion date
December 31, 2035
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, autoimmunity, cardiomyopathies, catheter ablation, genetic predisposition, immunosuppression, inflammatory cardiomyopathy, myocarditis, ventricular arrythmia